Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide differs from semaglutide in its combined GLP-1 agonist and glucose-dependent insulinotropic polypeptide (GIP) agonist action
This mechanism slows gastric emptying, increases feelings of fullness, and reduces appetite through brain signals, not stimulation
This drug takes a dual-action approach by targeting two different hormonal pathways involved in appetite and weight regulation: the GLP-1 and amylin pathways
Always work closely with your healthcare provider to tailor your treatment plan to your specific needs and risks
US$ 27.33
US$ 27.45
/images/2025/03/06/80a97023-8cda-4f9b-9f34-acfd82496b14.png)
US$ 28.95
US$ 28.57
US$ 29.05
